Related Experiment Videos
Costs and utilization associated with pharmaceutical adherence in a diabetic population
Kera L Hepke1, Mary T Martus, David A Share
1Blue Cross Blue Shield of Michigan, Detroit, Mich, USA.
The American Journal of Managed Care
|March 10, 2004
Summary
Increased adherence to diabetes medication improves patient well-being and reduces medical service use. However, overall healthcare costs did not decrease due to offsetting medication expenses.
Area of Science:
- Health Economics
- Pharmaceutical Adherence
- Diabetes Management
Background:
- Diabetes mellitus is a chronic condition requiring long-term management.
- Adherence to prescribed pharmaceutical therapies is crucial for effective disease control.
- Understanding the impact of adherence on healthcare costs and patient well-being is essential for optimizing treatment strategies.
Purpose of the Study:
- To investigate the relationship between adherence to pharmaceutical therapy and patient well-being.
- To determine the effect of medication adherence on the total costs associated with diabetes treatment.
Main Methods:
- Retrospective cohort study utilizing insurance claims data.
- Inclusion of patients under 65 with diabetes, continuously enrolled, and eligible for medical and drug coverage.
- Analysis of adherence levels, healthcare utilization, and medical costs, controlling for demographic and clinical factors.
Main Results:
- Increased pharmaceutical adherence correlated with reduced emergency department visits and hospital admissions.
- Higher medication adherence was linked to decreased medical care costs.
- A threshold effect was noted, requiring a target adherence level to achieve cost reductions.
Conclusions:
- Enhanced adherence to diabetes medications is associated with improved disease control and patient well-being.
- Despite reduced medical service utilization, overall healthcare costs were not lowered due to increased medication expenses.